-
1.
公开(公告)号:CL2021001826A1
公开(公告)日:2022-01-14
申请号:CL2021001826
申请日:2021-07-08
Applicant: BASF SE
Inventor: GOCKEL BIRGIT , KLAUBER ERIC GEORGE , RACK MICHAEL , SOERGEL SEBASTIAN , GOETZ ROLAND , VOGT FLORIAN , GEBHARDT JOACHIM , VIERTELHAUS MARTIN , CHIODO TIZIANA , XU WEN
IPC: C07D403/12
Abstract: La invención describe a una forma cristalina de 1-(1,2-dimetilpropil)-N-etil-5-metil-N-piridazin-4-il-pirazol-4-carboxamida a la que recientemente se le asignó el nombre común dimpropyridaz y al uso de dicha forma cristalina B para combatir plagas de invertebrados y a formulaciones para la protección de plantas.
-
公开(公告)号:CA2955570A1
公开(公告)日:2016-02-11
申请号:CA2955570
申请日:2015-08-03
Applicant: BASF SE
Inventor: VIERTELHAUS MARTIN , CHIODO TIZIANA , SALVADOR BEATE , VOSSEN MARCUS , HAFNER ANDREAS , HINTERMANN TOBIAS , WEISHAAR WALTER , HELLMANN ROLF
IPC: C07D213/40
Abstract: The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and sol-vents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.
-
公开(公告)号:MA54689A
公开(公告)日:2022-04-20
申请号:MA54689
申请日:2020-01-10
Applicant: BASF SE
Inventor: CHIODO TIZIANA , GEBHARDT JOACHIM , GOCKEL BIRGIT , GOETZ ROLAND , KLAUBER ERIC GEORGE , RACK MICHAEL , SOERGEL SEBASTIAN , VIERTELHAUS MARTIN , VOGT FLORIAN , XU WEN
IPC: C07D403/12
-
公开(公告)号:BR112021011492A2
公开(公告)日:2021-08-31
申请号:BR112021011492
申请日:2020-01-10
Applicant: BASF SE
Inventor: GOCKEL BIRGIT , ERIC GEORGE KLAUBER , VOGT FLORIAN , GEBHARDT JOACHIM , VIERTELHAUS MARTIN , RACK MICHAEL , GOETZ ROLAND , SOERGEL SEBASTIAN , CHIODO TIZIANA , XU WEN
IPC: C07D403/12
Abstract: forma b cristalina, 1-(1,2-dimetilpropil)-n-etil-5-metil-npiridazin-4-ilpirazol-4-carboxamida sólida, formulações de proteção vegetal, líquido de pulverização aquoso, uso da forma b cristalina, métodos de combate ou controle de pragas invertebradas e de proteção de safras. a presente invenção refere-se a uma forma cristalina de 1-(1,2-dimetilpropil)-n-etil-5-metil-n-piridazin-4-ilpirazol-4-carboxamida inovadora, que recebeu recentemente o nome comum dimpropiridaz. a presente invenção também se refere ao uso da forma cristalina b para combate a pragas invertebradas e formulações de proteção vegetal que contêm a forma cristalina b de 1-(1,2-dimetilpropil)-n-etil-5-metil-n-piridazin-4-ilpirazol-4-carboxamida. a forma cristalina b de acordo com a presente invenção pode ser identificada por meio de difratometria de raios x de pó com base no seu diagrama de difração de raios x de pó, também denominado a seguir padrão de difração de raios x de pó ou padrão pxrd, ou a forma polimórfica b registrada utilizando radiação cu-ka (1,54178 å) a 25 °c exibe os três reflexos a seguir, indicados como valores 20: 20,69 ± 0,10?, 24,15 ± 0,10º e 30,52 ± 0,10º. além desses três reflexos, o polimorfo b de acordo com a presente invenção pode exibir nesse padrão pxrd um ou mais, particularmente pelo menos 2, frequentemente pelo menos 4, particularmente pelo menos 6 ou pelo menos 8 reflexos, especialmente todos os reflexos indicados a seguir como valores 20: 7,99 ± 0,10º, 10,07 ± 0,10º, 12,38 ± 0,10º, 15,31 ± 0,10º, 15,97 ± 0,10º, 16,50 ± 0,10º, 18,03 ± 0,10º, 19,29 ± 0,10º, 20,22 ± 0,10º, 20,96 ± 0,10º, 23,40 ± 0,10º, 23,70 ± 0,10º, 26,09 ± 0,10º, 27,26 ± 0,10º e 32,91 ±0,10º.
-
公开(公告)号:AU2019362595A1
公开(公告)日:2021-04-29
申请号:AU2019362595
申请日:2019-10-17
Applicant: BASF SE
Inventor: VIERTELHAUS MARTIN , PUHL MICHAEL , WLOCH SEBASTIAN , OEDMAN PETER , LETZEL ANNE-CATRIN , SCHROEDER HARTWIG , MALISZ JACEK , SEIBERT-LUDWIG DANIEL , KAPPERT EMIEL JAN , WONG CHUNG HUAN , BARROS GROSS MICHAEL
Abstract: Crystalline form II of 2'-O-fucosyl lactose having an X-ray powder diffraction pattern comprising three reflections at 2θ angles (13.65 ± 0.20)°, (16.98 ± 0.20)° and (18.32 ± 0.20)°, determined at a temperature of 25 °C with Cu-Kα
-
公开(公告)号:AU2019362595B2
公开(公告)日:2024-12-19
申请号:AU2019362595
申请日:2019-10-17
Applicant: BASF SE
Inventor: VIERTELHAUS MARTIN , PUHL MICHAEL , WLOCH SEBASTIAN , OEDMAN PETER , LETZEL ANNE-CATRIN , SCHROEDER HARTWIG , MALISZ JACEK , SEIBERT-LUDWIG DANIEL , KAPPERT EMIEL JAN , WONG CHUNG HUAN , BARROS GROSS MICHAEL
Abstract: Crystalline form II of 2'-O-fucosyl lactose having an X-ray powder diffraction pattern comprising three reflections at 2θ angles (13.65 ± 0.20)°, (16.98 ± 0.20)° and (18.32 ± 0.20)°, determined at a temperature of 25 °C with Cu-Kα
-
公开(公告)号:AU2018373514A1
公开(公告)日:2020-05-14
申请号:AU2018373514
申请日:2018-11-08
Applicant: BASF SE
Inventor: VIERTELHAUS MARTIN , HELLMANN ROLF , KOULELIS DENNIS , SEISER TOBIAS
IPC: C07D403/14 , A01N43/54
Abstract: The present invention relates to crystalline forms of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3- methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, herein after also referred to as "compound of formula (I)". The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal compositions which contain one of these crystalline forms
-
公开(公告)号:CA2950485A1
公开(公告)日:2016-01-07
申请号:CA2950485
申请日:2015-06-24
Applicant: BASF SE
Inventor: VIERTELHAUS MARTIN , CHIODO TIZIANA , SALVADOR BEATE , VOSSEN MARCUS , HAFNER ANDREAS , HINTERMANN TOBIAS , SZELAGIEWICZ MARTIN , BLATTER FRITZ
IPC: C07D417/12 , A61K31/506
Abstract: The present invention primarily relates to multicomponent crystals comprising a compound of formula 1 and a second compound selected from the group consisting of menthol and vanillin. The invention is further related to pharmaceutical compositions comprising such multicomponent crystals. Furthermore, the invention relates to processes for preparing said multicomponent crystals. The invention also relates to several aspects of using said multicomponent crystals or pharmaceutical compositions to treat a disease.
-
9.
公开(公告)号:UA129323C2
公开(公告)日:2025-03-19
申请号:UAA202104305
申请日:2020-01-10
Applicant: BASF SE
Inventor: GEBHARDT JOACHIM , VIERTELHAUS MARTIN , CHIODO TIZIANA , RACK MICHAEL , KLAUBER ERIC GEORGE , XU WEN , GOETZ ROLAND , VOGT FLORIAN , GOCKEL BIRGIT , SOERGEL SEBASTIAN
Abstract: Данийвинахідналежитьдоновоїкристалічноїформи 1-(1,2-диметилпропіл)-N-етил-5-метил-N-піридазин-4-іл-піразол-4-карбоксаміду, якомунещодавнонаданозагальнуназвудимпропіридаз. Винахідтакожналежитьдозастосуваннякристалічноїформи B дляборотьбиз безхребетнимишкідникамиі доскладівдлязахистурослин, якімістятькристалічнуформу B 1-(1,2-диметилпропіл)-N-етил-5-метил-N-піридазин-4-іл-піразол-4-карбоксаміду. Кристалічнаформа B відповіднододаноговинаходуможебутиідентифікованазадопомогоюпорошковоїрентгенівськоїдифрактометріїнаосновіїїдіаграмипорошковоїрентгенівськоїдифракції, надалітакожназиваютьпорошковоїрентгенівськоїдифракційноюкартиноюабоПРДкартиною, поліморфноїформи B, записаноїз використаннямвипромінення Cu-Kα (1.54178 Å) при 25 (C відображує 3 наступнихвідбиття, зазначенихякзначення 2θ: 20,69,0,101, 24,15,0,101 і 30,52 0,101. Надодатокдоцихтрьохвідбиттівполіморф B відповіднододаноговинаходуможевідбиватив такійПРДкартиніоднеабодекілька, зокрема, щонайменше 2, частощонайменше 4, зокрема, щонайменше 6 абощонайменше 8 відбиттіві особливовсіз відбиттів, зазначенихнижчеякзначення 2θ: 7,99,0,101, 10,07,0,101, 12,38,0,101, 15,31,0,101, 15,97,0,101, 16,50,0,101, 18,03,0,101, 19,29,0,101, 20,22,0,101, 20,96,0,101, 23,40,0,101, 23,70,0,101, 26,09,0,101, 27,26,0,101 і 32,91 0,101.
-
公开(公告)号:AU2019360630B2
公开(公告)日:2022-10-27
申请号:AU2019360630
申请日:2019-10-17
Applicant: BASF SE
Inventor: PUHL MICHAEL , WLOCH SEBASTIAN , OEDMAN PETER , LETZEL ANNE-CATRIN , SCHROEDER HARTWIG , MALISZ JACEK , SEIBERT-LUDWIG DANIEL , KAPPERT EMIEL JAN , WONG CHUNG HUAN , BARROS GROSS MICHAEL , VIERTELHAUS MARTIN
Abstract: The present invention relates to a method for obtaining crystalline 2'-fucosyllactose from a 2'-FL raw material, which contains 2'-FL as a main constituent and at least 0.5% by weight, frequently at least 1% by weight, in particular at least 2% by weight, more particularly at least 5% by weight, and especially at least 8% by weight,based on the total amount of mono-and oligosaccharides in the raw material, of one or more mono- or oligosaccharides different from 2'-FL, where the method comprises a)providing a solution of the 2'-FL raw material in water, which does not contain more than 10% by weight, preferably not more than 7% by weight, more preferably not more than 5% by weight of organic solvents, based on the total amount of water; b) effecting the crystallization of 2'-FL from the solution provided in step a) by inducing conditions of a controlled super saturation in the solution; and c) separating crystalline 2'-FL from the mother liquor, and where during controlled supersaturation in step b) not more than 10% by weight, preferably not more than 7% by weight, more preferably not more than 5% by weight of organic solvents are present, based on the total amount of water present during step b).
-
-
-
-
-
-
-
-
-